Simon N Pimstone Insider Profile
11 Followers
Simon N Pimstone, Director at Eupraxia Pharmaceuticals, holds 48.68K shares in Eupraxia Pharmaceuticals (Ticker: TSE:EPRX), holds 22.46K shares in Xenon (Ticker: XENE). Most recently, Simon N Pimstone Bought ― shares of Eupraxia Pharmaceuticals on Mar 28, 2026 for an estimated value of C$113.51K.
Simon N Pimstone Eupraxia Pharmaceuticals (EPRX)Director
Eupraxia Pharmaceuticals (EPRX)
Director
Ranked #68,298 out of 108,437 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
-10.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Simon N Pimstone holds in companies
Most Profitable Insider Trade
The most profitable trade made by Simon N Pimstone
Simon N Pimstone's Trading History
Eupraxia Pharmaceuticals
Mar 28, 2026
Director
Informative Buy
113.51K
C$437.13K
Xenon
―
Chairman
―
$1.41M
List of latest transactions for each holding click on a transaction to see Simon N Pimstone's performance on stock
You May Also Like
Simon N Pimstone insider profile FAQ
What is the percentage of profitable transactions made by Simon N Pimstone?
The percentage of profitable transactions made by Simon N Pimstone is 67%.
What is the average return per transaction made by Simon N Pimstone?
The average return per transaction made by Simon N Pimstone is -10.90%.
What stocks does Simon N Pimstone hold?
Simon N Pimstone holds: TSE:EPRX, XENE stocks.
What was Simon N Pimstone’s latest transaction?
Simon N Pimstone latest transaction was an Informative Buy of C$113.51K.
What was Simon N Pimstone's most profitable transaction?
Simon N Pimstone’s most profitable transaction was an Informative Buy of TSE:EPRX stock on September 25, 2025. The return on the trade was 17.50%.
What is Simon N Pimstone's role in Eupraxia Pharmaceuticals?
Simon N Pimstone's role in Eupraxia Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.